ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 162 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $28,000 | -83.3% | 2,877 | -79.1% | 0.00% | – |
| Q4 2020 | $168,000 | +290.7% | 13,796 | +231.5% | 0.00% | – |
| Q3 2020 | $43,000 | -65.9% | 4,162 | -30.3% | 0.00% | – |
| Q2 2020 | $126,000 | +59.5% | 5,971 | -12.4% | 0.00% | – |
| Q4 2019 | $79,000 | +203.8% | 6,817 | +44.0% | 0.00% | – |
| Q3 2019 | $26,000 | -51.9% | 4,735 | +5.2% | 0.00% | – |
| Q2 2019 | $54,000 | +2600.0% | 4,502 | +486.2% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 768 | +104.3% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 376 | -2.8% | 0.00% | – |
| Q2 2018 | $2,000 | -33.3% | 387 | -64.5% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 1,089 | +34.6% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 809 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | – | 809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 5,068,233 | $17,739,000 | 5.88% |
| Sonic Fund II, L.P. | 6,552,068 | $22,932,000 | 1.69% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $1,680,000 | 0.88% |
| Avoro Capital Advisors LLC | 6,950,000 | $24,325,000 | 0.42% |
| RTW INVESTMENTS, LP | 7,357,917 | $25,753,000 | 0.39% |
| K2 PRINCIPAL FUND, L.P. | 898,307 | $3,144,000 | 0.26% |
| Artal Group S.A. | 3,000,000 | $10,500,000 | 0.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,827,000 | $9,895,000 | 0.18% |
| WS MANAGEMENT LLLP | 307,442 | $1,076,000 | 0.11% |
| ALGERT GLOBAL LLC | 82,145 | $288,000 | 0.10% |